NUVB - Nuvation Bio GAAP EPS of -$0.10 beats by $0.02 March, 15 2023 05:09 PM Nuvation Bio Inc. Class A 2023-03-15 17:09:08 ET Nuvation Bio press release ( NYSE: NUVB ): Q4 GAAP EPS of -$0.10 beats by $0.02 . As of December 31, 2022, Nuvation Bio had cash, cash equivalents and marketable securities of $661.0 million. For further details see: Nuvation Bio GAAP EPS of -$0.10 beats by $0.02